<unk>  (marketed under the brand name Deracyn) is a tranquilizer of the triazolobenzodiazepine (TBZD) class, which are benzodiazepines (BZDs) fused with a triazole ring. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties.<unk>  was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed.<unk>  was never FDA approved and never made available to the public market, however it has been sold as a designer drug.
Adinazolam
Remimazolam
Haloxazolam
Ketazolam
Midazolam
Triazolam
Flutazolam
Cloxazolam